National Institute on Drug Abuse; Notice of Closed Meetings, 70662-70663 [E8-27530]
Download as PDF
<![CDATA[
70662
Federal Register / Vol. 73, No. 226 / Friday, November 21, 2008 / Notices
Mid-Atlantic Region and Pennsylvania,
Federal Archives and Records Center, 14700
Townsend Road, Philadelphia, Pennsylvania
19154–1096.
Alabama, Florida, Georgia, Kentucky,
Mississippi, North Carolina, South Carolina,
and Tennessee, Federal Archives and
Records Center, 1557 St. Joseph Avenue, East
Point, Georgia 30344–2593.
Illinois, Indiana, Michigan, Minnesota,
Ohio and Wisconsin and U.S. Court Records
for the mentioned States, Federal Archives
and Records Center, 7358 South Pulaski
Road, Chicago, Illinois 60629–5898.
Michigan, Except U.S. Court Records,
Federal Records Center, 3150 Springboro
Road, Dayton, Ohio 45439–1883.
Kansas, Iowa, Missouri and Nebraska, and
U.S. Court Records for the mentioned States,
Federal Archives and Records Center, 2312
East Bannister Road, Kansas City, Missouri
64131–3011.
New Jersey, New York, Puerto Rico, and
the U.S. Virgin Islands, and U.S. Court
Records for the mentioned States and
territories, 200 Space Center Drive, Lee’s
Summit, Missouri 64064–1182.
Arkansas, Louisiana, Oklahoma and Texas,
and U.S. Courts Records for the mentioned
States, Federal Archives and Records Center,
P.O. Box 6216, Ft. Worth, Texas 76115–0216.
Colorado, Wyoming, Utah, Montana, New
Mexico, North Dakota, and South Dakota,
and U.S. Courts Records for the mentioned
States, Federal Archives and Records Center,
P.O. Box 25307, Denver, Colorado 80225–
0307.
Northern California Except Southern
California, Hawaii, and Nevada Except Clark
County, the Pacific Trust Territories, and
American Samoa, and U.S. Courts Records
for the mentioned States and territories,
Federal Archives and Records Center, 1000
Commodore Drive, San Bruno, California
94066–2350.
Arizona, Southern California, and Clark
County, Nevada, and U.S. Courts Records for
the mentioned States, Federal Archives and
Records Center, 23123 Cajalco Road, Perris,
California 93570–7298.
Washington, Oregon, Idaho and Alaska,
and U.S. Courts Records for the mentioned
States, Federal Archives and Records Center,
6125 Sand Point Way NE, Seattle,
Washington 98115–7999.
[FR Doc. E8–27708 Filed 11–20–08; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
dwashington3 on PRODPC61 with NOTICES
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
VerDate Aug<31>2005
14:24 Nov 20, 2008
Jkt 217001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; AA–1 Member Conflict
Review.
Date: January 21, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane, 2085,
Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Abraham P. Bautista, PhD,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse &
Alcoholism, National Institutes of Health,
5635 Fishers Lane, Rm 3039, Rockville, MD
20852, 301–443–9737,
bautista@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: November 13, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–27528 Filed 11–20–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIDA.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Drug Abuse,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: December 18, 2008.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Intramural Research Program,
National Institute on Drug Abuse, NIH, Johns
Hopkins Bayview Campus, Baltimore, MD
21224.
Contact Person: Stephen J. Heishman, PhD,
Research Psychologist, Clinical
Pharmacology Branch, Intramural Research
Program, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 5500
Nathan Shock Drive, Baltimore, MD 21224,
(410) 550–1547.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: November 13, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–27529 Filed 11–20–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Electronic Drug Abuse Treatment Referral
Systems for Physicians.
Date: December 4, 2008.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
E:\FR\FM\21NON1.SGM
21NON1
dwashington3 on PRODPC61 with NOTICES
Federal Register / Vol. 73, No. 226 / Friday, November 21, 2008 / Notices
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Virtual
Reality Simulations to Train Caregivers/
Providers.
Date: December 4, 2008.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Design
and Synthesis of Treatment Agents for Drug
Abuse.
Date: December 10, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401. 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Web
Based Cognitive/Neuropsychological Testing
for Substance Abuse.
Date: December 12, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Development of Therapeutic Agents for
Substance Use Disorders.
Date: December 16, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852.
(Telephone Conference Call)
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Pharmaceutical Approaches for Development
of Pharmacotherapies for Drug Addiction.
VerDate Aug<31>2005
14:24 Nov 20, 2008
Jkt 217001
Date: December 17, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse, Special Emphasis Panel,
Screening, Characterization and Validation
Assays for Protein Capture Reagents.
Date: December 18, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
Proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Rapid
Assessment Tools of Sexual and Drug Use
Risk Behaviors.
Date: January 8, 2009.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Tool
Development for New or Improved Capture
Reagents.
Date: January 9, 2009.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Development of Science Education Materials
or Programs.
Date: January 13, 2009.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
70663
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Instrument Development.
Date: January 15, 2009.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: November 13, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–27530 Filed 11–20–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 73, Number 226 (Friday, November 21, 2008)]
[Notices]
[Pages 70662-70663]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27530]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Electronic Drug Abuse Treatment Referral Systems for
Physicians.
Date: December 4, 2008.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs,
[[Page 70663]]
National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401,
6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1439,
lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Virtual Reality Simulations to Train Caregivers/
Providers.
Date: December 4, 2008.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Design and Synthesis of Treatment Agents for Drug
Abuse.
Date: December 10, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401. 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Web Based Cognitive/Neuropsychological Testing for
Substance Abuse.
Date: December 12, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Development of Therapeutic Agents for Substance Use
Disorders.
Date: December 16, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852. (Telephone Conference Call)
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Pharmaceutical Approaches for Development of
Pharmacotherapies for Drug Addiction.
Date: December 17, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse, Special
Emphasis Panel, Screening, Characterization and Validation Assays
for Protein Capture Reagents.
Date: December 18, 2008.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract Proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Rapid Assessment Tools of Sexual and Drug Use Risk
Behaviors.
Date: January 8, 2009.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard,
Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Tool Development for New or Improved Capture
Reagents.
Date: January 9, 2009.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Development of Science Education Materials or
Programs.
Date: January 13, 2009.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard,
Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Instrument Development.
Date: January 15, 2009.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard,
Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: November 13, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-27530 Filed 11-20-08; 8:45 am]
BILLING CODE 4140-01-M
